Synapse - Works

Results (714)

Clinical characteristics and outcome of childhood Li-Fraumeni syndrome medulloblastoma patients

Meeting Abstract

Kolodziejczak, A.; Guerrini-Rousseau, L.; Planchon, J. M.; Mynarek, M.; Sill, M.; Autry, R.; Zhao, E.; Hirsch, S.; Dufour, C.; Ayrault, O.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Non-invasive diagnosis of brainstem gliomas in pediatric, adolescent, and young adult patients through cerebrospinal fluid cell-free DNA sequencing

Meeting Abstract

Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B.; Alano, T.; Doe-Tetteh, S.; Bouvier, N.; Li, S.; Stockfisch, E.; Huereca, C.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

A phase 1 study of savolitinib in recurrent, progressive, or refractory medulloblastoma, high-grade glioma, diffuse intrinsic pontine glioma, and central nervous system (CNS) tumors harboring met aberrations: A Pediatric Brain Tumor Consortium trial

Meeting Abstract

Salloum, R.; Huang, J.; Stewart, C. F.; Fuller, C.; Smolarek, T.; Lenzen, A.; Waanders, A. J.; Baxter, P.; Lindsay, H.; Robison, N.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Minimally-invasive diagnosis of diffuse leptomeningeal glioneuronal tumor (DLGNT) using cerebrospinal fluid cell-free DNA sequencing in pediatric and young adult patients

Meeting Abstract

Larsen, A. G.; Hill, K.; Hickman, R.; Bale, T.; Holle, B.; Mellinghoff, I.; Dunkel, I.; Souweidane, M.; Greenfield, J.; Sait, S. F.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Landscape of FGFR alterations in pediatric and AYA gliomas

Meeting Abstract

Nobre, L.; Sait, S. F.; Bennet, J.; Larsen, A. G.; Ho, I. C.; Gianno, F.; Lin, A.; Mellinghoff, I.; Miller, A.; Siddaway, R.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Diffuse midline glioma with extracranial metastasis

Meeting Abstract

Larsen, A. G.; Rivera, M.; Pisapia, D.; Sait, S. F.; Karajannis, M.; Greenfield, J.; Souweidane, M.
Neuro-Oncology (2023)

Fulltext@MSK | Save

Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908

Journal Article

Dunkel, I. J.; Doz, F.; Foreman, N. K.; Hargrave, D.; Lassaletta, A.; Andre, N.; Hansford, J. R.; Hassall, T.; Eyrich, M.; Gururangan, S.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors - A prospective study and guidelines for clinical testing

Journal Article

Galbraith, K.; Vasudevaraja, V.; Serrano, J.; Shen, G.; Tran, I.; Abdallat, N.; Wen, M.; Patel, S.; Movahed-Ezazi, M.; Faustin, A.; more...
Neuro-Oncology Advances (2023)

Fulltext@MSK | Save

Cerebrospinal fluid: The new frontier for methylome-based diagnostic classification of brain tumors

Editorial

Miller, A. M.; Karajannis, M. A.
Neuro-Oncology (2023)

Fulltext@MSK | Save

Slipped capital femoral epiphyses: A major on‐target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients

Journal Article

Farouk Sait, S.; Fischer, C.; Antal, Z.; Spatz, K.; Prince, D. E.; Ibanez, K.; Behr, G. G.; Dunkel, I. J.; Karajannis, M. A.
Pediatric Blood and Cancer (2023)

Fulltext@MSK | Save